Low-Dose Naltrexone During Perimenopause: Could It Support Your Treatment Plan?
Low-dose naltrexone is becoming part of the conversation around inflammation, chronic pain, and persistent symptoms during perimenopause. Here is what LDN is, how it may work, and where it could fit alongside an individualized hormone optimization plan.
If you follow hormone or wellness content, you may have started seeing the abbreviation “LDN.”
Perhaps someone you know has tried it, you have seen it discussed online, or a healthcare provider has mentioned it as a possible option. Although interest in LDN continues to grow, it can be difficult to separate promising possibilities from proven benefits.
Let’s take a closer look at what low-dose naltrexone is, how it is thought to work, and why some providers are considering it for women whose symptoms have improved—but not completely resolved—with hormone therapy and other foundational treatments.
What Is Low-Dose Naltrexone?
Naltrexone is a prescription medication that has been used for decades. At its standard dose, it is FDA-approved for the treatment of alcohol use disorder and opioid dependence.
Low-dose naltrexone generally refers to much smaller doses—often between 0.5 and 4.5 mg daily—used for purposes that are considered off-label.
At these lower doses, naltrexone is believed to temporarily block certain opioid receptors. Researchers have proposed that this brief blockade may influence the body’s natural endorphin activity and help regulate pain signaling, immune activity, and inflammation. LDN may also affect microglial cells, which are immune cells within the central nervous system.
However, these mechanisms are still being studied and are not yet fully understood. Published research describes LDN as a promising but still experimental approach for inflammatory and chronic pain conditions.
Rather than completely suppressing the immune system, LDN is thought to help modulate certain inflammatory and pain-related pathways.
Why Is LDN Being Discussed During Perimenopause?
Perimenopause involves more than changing estrogen and progesterone levels. Hormonal fluctuations can also influence the nervous system, immune function, pain perception, sleep, mood, and metabolic health.
Research has described the menopausal transition as a time when inflammatory activity may change within both the body and the central nervous system. However, this does not mean that inflammation is responsible for every symptom or that every woman will benefit from an anti-inflammatory treatment.
Some women improve significantly after their hormones, nutrition, sleep, stress, thyroid function, and metabolic health are addressed. Others continue to experience pain, fatigue, disrupted sleep, brain fog, or inflammatory symptoms despite making progress in those areas.
In carefully selected patients, LDN may be considered as an additional tool. It is important to understand, however, that research directly studying LDN as a treatment for perimenopause is currently limited.
What Symptoms Might LDN Support?
LDN is not a hormone and does not replace estrogen, progesterone, or testosterone. Instead, it works through different pathways that may affect inflammation, pain processing, and immune activity.
Depending on a woman’s medical history and remaining symptoms, a provider may consider LDN for concerns such as:
Persistent joint or muscle discomfort
Chronic or widespread pain
Inflammatory symptoms that have not responded fully to foundational treatment
Sleep disruption related to discomfort
Fatigue or brain fog occurring alongside a chronic pain or inflammatory condition
Certain autoimmune or immune-related symptoms
Much of the available LDN research has focused on conditions such as fibromyalgia, multiple sclerosis, Crohn’s disease, and other chronic pain disorders—not perimenopause itself. Some early studies have reported improvement, while other trials have shown less convincing results.
LDN is also sometimes discussed for appetite, cravings, or “food noise.” Standard-dose naltrexone affects reward and craving pathways, and naltrexone is included with bupropion in an FDA-approved weight-management medication. However, that does not establish low-dose naltrexone alone as an effective treatment for appetite or weight loss.
If food noise or appetite changes are significant concerns, it is important to evaluate hormones, blood sugar regulation, sleep, stress, nutrition, medications, and other possible contributors rather than assuming LDN is the answer.
How Can LDN Fit Alongside Hormone Therapy?
Hormone therapy and LDN are intended to address different aspects of a woman’s health.
An individualized hormone plan may be used to address symptoms associated with changing hormone levels, such as hot flashes, night sweats, vaginal symptoms, sleep disruption, or other appropriate concerns. LDN does not correct a hormone deficiency or replace the benefits of properly prescribed hormone therapy.
Instead, LDN may be considered when pain, inflammatory symptoms, or certain immune-related concerns remain after the hormonal and foundational pieces of the plan have been addressed.
For some women, this may mean using hormone therapy as the foundation while exploring LDN as an additional layer of support. For others, persistent symptoms may point to a different issue entirely, such as thyroid dysfunction, insulin resistance, nutrient deficiencies, an autoimmune condition, inadequate recovery, or chronic stress.
The goal is not to add another prescription automatically. It is to determine why symptoms remain and choose the most appropriate next step.
What Does Starting LDN Look Like?
LDN requires a prescription and is commonly prepared by a compounding pharmacy because the commercially available tablets are much stronger than the doses generally used for LDN.
Although every treatment plan should be individualized, here is what patients can typically expect:
Treatment usually begins with a low dose
Some providers begin around 0.5 or 1.5 mg daily and slowly increase the dose based on tolerance and response. There is no single dose that is right for everyone, and research has shown considerable variation in how individuals respond.
The dose is increased gradually
A slow titration may help reduce early side effects. Reported effects can include vivid dreams, sleep changes, headache, nausea, or gastrointestinal discomfort. In available studies, LDN has generally been well tolerated, but research regarding its long-term use remains limited.
Timing can be adjusted
LDN is frequently taken in the evening, but nighttime dosing is not required for every patient. If it causes vivid dreams or interferes with sleep, a provider may recommend taking it earlier in the day.
Improvement may take time
LDN is not typically viewed as a fast-acting medication. A provider may recommend a monitored trial lasting several weeks before deciding whether it is helping. The response should be based on measurable changes in the specific symptoms being treated.
Follow-up is important
Your provider should monitor your symptoms, side effects, medication list, and overall response. The dose can then be adjusted—or the medication discontinued—if it is not providing a meaningful benefit.
An Important Safety Consideration
LDN should not be started without reviewing all current medications.
Because naltrexone blocks opioid receptors, it can interfere with opioid pain medications and may trigger withdrawal in someone who is physically dependent on opioids. This includes certain prescription pain medications and some opioid-containing cough or diarrhea products. Anyone anticipating surgery or a procedure that may require opioid pain control should also discuss this with the prescribing provider.
Your provider should also review your liver health, medical history, pregnancy status, and other medications before prescribing LDN.
Is Low-Dose Naltrexone Right for You?
If your current treatment plan is working and your symptoms have resolved, there may be no reason to add LDN.
However, if your hormones and foundational health needs have been addressed and you continue to experience persistent pain, inflammatory symptoms, disrupted sleep related to discomfort, or certain immune-related concerns, LDN may be worth discussing.
It is not a universal solution, and it should not be used as a substitute for identifying the underlying cause of ongoing symptoms. The evidence is promising in some conditions, but LDN has not been proven to treat perimenopause itself.
The right conversation should include:
Your complete medical history
All medications and supplements you currently take
Any current or anticipated opioid use
The specific symptoms that remain
What other underlying causes have been evaluated
How improvement will be measured
The goal is not to continue adding medications. It is to create a thoughtful, personalized plan that addresses the right systems and helps you feel and function your best.
If your hormone plan is working but something still feels unresolved, schedule a consultation. Together, we can look more closely at your symptoms, health history, and treatment options to determine whether LDN may be an appropriate addition to your personalized plan.